A Comparative Study Minisling Versus Transobturator (TOT)Sling (sui)
This study is enrolling participants by invitation only.
Sponsor:
Federal University of São Paulo
Information provided by:
Federal University of São Paulo
ClinicalTrials.gov Identifier:
NCT01094353
First received: March 24, 2010
Last updated: March 25, 2010
Last verified: March 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
A study to compare efficacy in surgical treatment for SUI (Stress Urinary Incontinence), tot with minisling.
| Condition | Intervention | Phase |
|---|---|---|
|
Female Stress Urinary Incontinence |
Procedure: minisling ophira™ |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Randomised Trial of Ophira™ Minisling System and Unitape™ for the Treatment of Stress Urinary Incontinence in Women |
Resource links provided by NLM:
Further study details as provided by Federal University of São Paulo:
Primary Outcome Measures:
- to assess efficacy between tot with minisling in cure in women with stress urinary incontinence [ Time Frame: one year ] [ Designated as safety issue: Yes ]to assess efficacy and safety of minisling and transobturator sling in treatment of female stress urinary incontinence
| Estimated Enrollment: | 50 |
| Study Start Date: | June 2008 |
| Estimated Study Completion Date: | January 2012 |
| Estimated Primary Completion Date: | January 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: minisling
The minisling Ophira™ is a new intervention therapeutic option for surgical treatment in women with stress urinary incontinence. It is made of polypropylene monofilament mesh, held between two self-anchoring polypropylene columns in a fishbone design connected to two delivering needles.
|
Procedure: minisling ophira™
The minisling is a new intervention therapeutic option for surgical treatment in women with stress urinary incontinence. It is made of polypropylene monofilament mesh, held between two self-anchoring polypropylene columns in a fishbone design connected to two delivering needles.
Other Names:
|
|
Active Comparator: transobturator
Transobturator sling Unitape™ is an outside-in approach therapeutic option for surgical treatment in women with stress urinary incontinence
|
Procedure: minisling ophira™
The minisling is a new intervention therapeutic option for surgical treatment in women with stress urinary incontinence. It is made of polypropylene monofilament mesh, held between two self-anchoring polypropylene columns in a fishbone design connected to two delivering needles.
Other Names:
|
Detailed Description:
eligibility criteria was : female stress urinary incontinence
Eligibility| Ages Eligible for Study: | 18 Years to 90 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- clinical and urodynamic diagnosis of SUI in patients between 18 and 90 years
Exclusion Criteria:
- postvoid residual urine volume more than 100 ml, coagulation disorders, current urinary tract infection, sequelae of previous radiation therapy of the pelvis, anticoagulant therapy, vulvovaginitis, and anesthesia contraindication
Contacts and Locations
More Information
Publications:
| Responsible Party: | unifesp |
| ClinicalTrials.gov Identifier: | NCT01094353 History of Changes |
| Other Study ID Numbers: | ophira |
| Study First Received: | March 24, 2010 |
| Last Updated: | March 25, 2010 |
| Health Authority: | Brazil: National Health Surveillance Agency |
Keywords provided by Federal University of São Paulo:
|
Urodynamic Stress urinary incontinence Minisling Ophira™ Unitape™ |
Additional relevant MeSH terms:
|
Urinary Incontinence Urinary Incontinence, Stress Urination Disorders |
Urologic Diseases Urological Manifestations Signs and Symptoms |
ClinicalTrials.gov processed this record on May 16, 2013